Results 261 to 270 of about 1,421,119 (326)

The Utility of CRT: Analyzing Systemic Issues in Community and Technical Colleges

New Directions for Community Colleges, EarlyView.
ABSTRACT This paper examines the underutilization of Critical Race Theory (CRT) in addressing systemic racial inequities within community and technical colleges (CTCs). We argue that while diversity, equity, and inclusion (DEI) initiatives are prevalent, CRT offers a more robust framework for understanding and dismantling systemic racism.
Yuritzi Lozano, Tenisha L. Tevis, Jason Boatwright, Danielle Hoffman   +3 more
wiley   +1 more source

Hypertensive Disorders of Pregnancy: A Literature Review - Pathophysiology, Current Management, Future Perspectives, and Healthcare Disparities. [PDF]

US Cardiol
Traub A, Sharma A, Gongora MC.
europepmc   +1 more source

Impact of Heart Failure and Chronic Kidney Disease on All‐Cause Mortality in Patients Undergoing Coronary Angiography: Results From the Finnish Kardio Multicentre Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Heart failure (HF) and chronic kidney disease (CKD) are common comorbidities among patients undergoing coronary angiography. Both conditions are associated with increased risk of adverse cardiovascular outcomes and mortality. However, the joint prognostic impact of HF and CKD in this patient population remains unclear. Aims We aimed
Jari A. Laukkanen, Jaakko Immonen, Jussi Hernesniemi, Mari Merentie, Ashish H. Shah, Markku Eskola, Sudhir Kurl, Setor K. Kunutsor   +7 more
wiley   +1 more source

Protocol for an Integrative Meta‐Analysis of the Application of Machine Learning Algorithms in the Prediction of Chronic Disease Risks and Outcomes

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Background Precise risk prediction of chronic diseases is essential for effective preventive care and management. Machine learning (ML) is a promising avenue to enhance chronic disease risk prediction; however, a comprehensive assessment of ML performance across various chronic diseases, populations, and health settings is needed. Methods This
Ebenezer Afrifa‐Yamoah, Emmanuel Peprah‐Yamoah, Enoch Odame Anto, Victor Opoku‐Yamoah, Eric Adua   +4 more
wiley   +1 more source

Healthcare disparities, screening, and molecular testing in the changing landscape of non-small cell lung cancer in the United States: a review. [PDF]

Cancer Metastasis Rev
Kurzrock R, Chaudhuri AA, Feller-Kopman D, Florez N, Gorden J, Wistuba II.   +5 more
europepmc   +1 more source

LGBTQ+ Affirmative Care Training in Counselor Education: A Community‐Based Inquiry

Counselor Education and Supervision, EarlyView.
ABSTRACT Counselor educators, counselors‐in‐training, and LGBTQ+ community members engaged in a community‐based qualitative inquiry exploring LGBTQ+ affirmative care education. Findings revealed counselor educators’ components and delivery of content, developmental implications for applying LGBTQ+ affirmative care, and gaps between education and LGBTQ+
Nancy E. Thacker Darrow, Kamden K. Strunk, Thea L. Racelis   +2 more
wiley   +1 more source

Clinically Important Endpoints in Individuals With Leukodystrophy: A Multisite Study

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Importance Leukodystrophies are a diverse group of rare disorders that disrupt central myelination. These disorders present with a broad spectrum of neurological severity and are associated with a range of potential secondary complications, such as scoliosis and failure of independent feeding.
Emma R. Kotes, Sarah Woidill, Russell D'Aiello, Amina Khan, Jacob McCann, Mark Ramos, Francesco Gavazzi, Stephanie Keller, Keith Van Haren, Ali Fatemi, Florian Eichler, Joshua Bonkowsky, Jamie Fraser, Lisa Emrick, Omar Sherbini, Ashley Hackett, Jeilo Gauna, Dandre Amos, Jordan Goodman, Amena Smith Fine, Amanda Nagy, Seungil Lee, Nicole Page, Johanna Schmidt, Amy Pizzino, Kayla Muirhead, Mariko Bennett, Amy Waldman, Justine Shults, Laura Adang, Robert Grundmeier, Adeline Vanderver   +31 more
wiley   +1 more source

Factors Influencing the Duration From the Initiation of Surgical Evaluation to Final Intervention in Pediatric Epilepsy Surgery

Annals of the Child Neurology Society, EarlyView.
ABSTRACT Rationale Longer duration of epilepsy before surgery is a predictor of poor outcome. While referral delays of surgical candidates are well documented, factors causing delay during the presurgical evaluation remain unclear and may vary depending on institutional characteristics.
Ruba Al‐Ramadhani, Ann Hyslop, Avery R. Caraway, Edward J. Novotny, Adam P. Ostendorf, Krista L. Eschbach, Allyson L. Alexander, Lily C. Wong‐Kisiel, Dewi F. Depositario‐Cabacar, Chima O. Oluigbo, Cemal Karakas, Samir R. Karia, Priyamvada Tatachar, Jeffrey Bolton, Pilar D. Pichon, Daniel W. Shrey, Erin Fedak Romanowski, Nancy A. McNamara, Ernesto Gonzalez‐Giraldo, Kurtis Auguste, Danilo Bernardo, Rani K. Singh, Pradeep K. Javarayee, Jenny J. Lin, Jason C. Coryell, Shilpa B. Reddy, Abhinaya Ganesh, Michael A. Ciliberto, Debopam Samanta, Kristen H. Arredondo, Ahmad Marashly, Zachary M. Grinspan, Dallas Armstrong, Taylor J. Abel, Janelle Wagner, Derryl J. Miller, Fernando N. Galan, Michael Scott Perry   +37 more
wiley   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source